According to the research report titled ‘U.S. Home Infusion Therapy Market Size By Product (Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors), By Application (Anti-infective, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals), Industry Analysis Report, Zonal Outlook (East North Central, West South Central, South Atlantic, North East, East South Central, West North Central, Pacific Central, Mountain States), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020 – 2026’, available with MarketStudyReport, U.S. home infusion therapy market is projected to witness considerable growth over 2020-2026.
 

Expanding presence of homecare facilities, technological advancements, rising pervasiveness of chronic diseases, and growing cases of hospital acquired infection are propelling U.S. home infusion therapy market growth.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/1173838/
 

For the uninitiated, home infusion is a clinically suitable treatment option for patients suffering from various acute and chronic diseases, ranging from bacterial infections to progressively complex conditions such as bleeding disorders, immunological deficiencies, late-stage heart failure, and nutrition support. It can be availed by patients from the comfort of their homes, as per their requirements. It also gives greater results, is cost-effective, and provides more safety.
 

Based on product type, IV cannulas segment garnered a valuation of USD 574.2 million in 2019 and is projected to exhibit 10.2% CAGR through 2026.  Intravenous cannulation, or IV cannulation, is a method that involves inserting a cannula into a vein to provide venous access. It helps obtain blood samples, and administer fluids, medicines, blood products, chemotherapy, and parenteral nutrition.
 

As per application scope, hydration segment of U.S. home infusion therapy industry amassed USD 170.2 million in 2019 and is predicted to multiply at a CAGR of 10.6% over the assessment period. Hydration treatment has various advantages, including increased immunity, enhanced recovery time, improved cognitive skills, removal of toxins from the body, efficiency, and better joint, skin, and muscle health.
 

Chemotherapy segment stood at USD 155.1 million in 2019 and is projected to register a CAGR of 10.6% over the study period. Meanwhile, specialty pharmaceuticals segment was valued at USD 1.1 billion in 2019 and is speculated to record 10.2% compound annual growth rate over 2020-2026.
 

Regionally, East North Central market size was worth USD 1.2 billion in the recent past, and it is expected to increase at a CAGR of 10.2% over the forecast period. The West South-Central market was valued at USD 853.0 million, and it is likely to develop at a CAGR of 5.1% over the next five years.
 

The East South-Central market value was USD 468.6 million and is touted to rise at a CAGR of 7.7% over the forecast period. Meanwhile, the Mountain States industry, valued USD 657.4 million in the past, is anticipated to increase at a CAGR of 11.5% through 2026.
 

Key players operating in U.S. home infusion therapy market sphere are Terumo Corporation, Smiths Medical Inc., Moog Inc., ICU Medical Inc., Halyard Health, Fresenius Kabi, and Becton Dickinson and Company (BD) among others.